Tech Company Financing Transactions
Mitochon Pharmaceuticals Funding Round
ALS Investment Fund participated in a $1 million funding round for Mitochon Pharmaceuticals. The round was announced on 8/20/2026.
Transaction Overview
Company Name
Announced On
8/20/2026
Transaction Type
Debt
Amount
$1,000,000
Round
Undisclosed
Investors
ALS Investment Fund (Kuldip Dave)
Proceeds Purpose
This funding will pave the way for a 24-week sporadic ALS study and expand upon recent clinical studies in Europe showing a quick drop in Neurofilament Light (NfL) in sporadic ALS participants taking MP-101 capsules.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
970 Cross Ln.
Blue Bell, PA 19422
USA
Blue Bell, PA 19422
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is to bring forward meaningful drugs that work at the root of insidious diseases by modulating the mitochondria directly to attenuate disease progression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Alonso
Chief Medical Officer
Marcus Keep
Chief Scientific Officer
John Geisler
Browse more venture capital transactions:
Prev: 8/20/2026: Muon Space venture capital transaction
Next: 8/20/2026: Paralo venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs